GIPR/GLP-1R dual agonist therapies for diabetes and weight loss—chemistry, physiology, and clinical applications is a research paper published in Cell Metabolism (2023). On theSindex it has a DataRank of 0. It has been cited 137 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
ERC
Grant: 101044445
European Research Council
Grant: 695054
Deutsche Forschungsgemeinschaft
Grant: GRK 2816/1
Deutsche Forschungsgemeinschaft
Grant: SFB1123
Deutsche Forschungsgemeinschaft
Grant: TRR152
Deutsche Forschungsgemeinschaft
Grant: TRR296
NIDDK
Grant: DK046492
NIDDK
Grant: DK123075
NIDDK
Grant: DK125353
NIDDK NIH HHS
Grant: R01 DK046492
NIDDK NIH HHS
Grant: R01 DK123075
NIDDK NIH HHS
Grant: T32 DK007012
NIDDK NIH HHS
Grant: R01 DK125353
NIDDK NIH HHS
Grant: R37 DK046492
National Institutes of Health
California Department of Fish and Game
Eli Lilly and Company
FWCI
21.18
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals